| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.8M | — | -4.7% |
| Cost of Revenue | $8.5M | — | -11.3% |
| Gross Profit | $12.2M | — | +0.5% |
| R&D Expense | $2.3M | — | +0.2% |
| SG&A Expense | $4.7M | — | -9.3% |
| Operating Income | -$1.2M | — | +97.6% |
| Interest Expense | $1.3M | — | — |
| Pre-tax Income | -$3.3M | — | +93.5% |
| Income Tax | $117K | — | +125.8% |
| Net Income | -$3.4M | — | +93.2% |
| EPS (Basic) | -$0.77 | — | +32.5% |
| EPS (Diluted) | -$0.77 | — | +32.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.1M | -17.6% | +28.0% |
| Accounts Receivable | $14.6M | -9.2% | +8.1% |
| Inventory | $22.2M | +6.7% | -2.7% |
| Current Assets | $47.5M | -1.5% | +5.7% |
| Total Assets | $77.9M | -2.7% | -2.3% |
| Current Liabilities | $23.9M | +8.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$662K | — | -122.2% |
| Capital Expenditures | $426K | — | -17.0% |
| Investing Cash Flow | -$620K | — | +9.2% |
| Financing Cash Flow | -$9K | — | +99.3% |
| Free Cash Flow | -$1.1M | — | -144.0% |
| -57.1% |
| Long-term Debt | $36.2M | +1.0% | -0.5% |
| Total Liabilities | $67.9M | +2.3% | +4.5% |
| Stockholders' Equity | $10.0M | -26.9% | -32.3% |